anandamide has been researched along with Ischemia* in 2 studies
2 other study(ies) available for anandamide and Ischemia
Article | Year |
---|---|
TASK-1 channels in oligodendrocytes: a role in ischemia mediated disruption.
Oligodendrocytes are the myelinating cells of the CNS and, like neurons, are highly sensitive to ischemic damage. However, the mechanisms underlying cytotoxicity in oligodendrocytes during hypoxic/ischemic episodes are not fully understood. TASK-1 is a K(+) leak channel that mediates hypoxic depolarisation in neurons. The expression and function of TASK-1 in oligodendrocytes had not previously been addressed. In this study, we investigate the expression of TASK-1 in oligodendrocytes and its role in white matter ischemic damage. Expression of TASK-1 in oligodendrocytes was investigated in the mouse brain using immunostaining. TASK-1 channel function was identified by established pharmacological and electrophysiological strategies, using the whole-cell patch clamp technique in cell cultures of oligodendrocytes from the optic nerve, a typical white matter tract. The role of TASK-1 in hypoxia was examined in isolated intact optic nerves subjected to oxygen glucose deprivation (OGD). Oligodendrocytes are strongly immunopositive for TASK-1 throughout the brain. Patch-clamp identified functional TASK-1-like leak currents in oligodendrocytes using two recognised means of inhibiting TASK-1, decreasing extracellular pH to 6.4 and exposure to the TASK-1 selective inhibitor anandamide. Incubation of optic nerves with methanandamide, a non-hydrolysable form of anandamide, significantly protected oligodendrocytes against hypoxic disruption and death in OGD. Our data demonstrate for the first time that oligodendrocytes express functional TASK-1 channels and provide compelling evidence they contribute to oligodendrocyte damage in hypoxia. Since oligodendrocyte damage is a key factor in ischemic episodes, TASK-1 may provide a potential therapeutic target in stroke and white matter disease. Topics: Animals; Animals, Newborn; Arachidonic Acids; Biophysical Phenomena; Brain; Calcium Channel Blockers; Electric Stimulation; Endocannabinoids; Gene Expression Regulation; Glucose; Hypoxia; Ischemia; Luminescent Proteins; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myelin Proteolipid Protein; Nerve Tissue Proteins; Neurons; Oligodendroglia; Optic Nerve; Organ Culture Techniques; Patch-Clamp Techniques; Polyunsaturated Alkamides; Potassium Channels, Tandem Pore Domain; Protons | 2013 |
Anandamide protects from low serum-induced apoptosis via its degradation to ethanolamine.
Anandamide (AEA) is a lipid molecule belonging to the family of endocannabinoids. Various studies report neuroprotective activity of AEA against toxic insults, such as ischemic conditions and excitotoxicity, whereas some show that AEA has pro-apoptotic effects. Here we have shown that AEA confers a protective activity in N18TG2 murine neuroblastoma cells subjected to low serum-induced apoptosis. We have demonstrated that the protection from apoptosis by AEA is not mediated via the CB1 receptor, the CB2 receptor, or the vanilloid receptor 1. Interestingly, breakdown of AEA by fatty acid amide hydrolase is required for the protective effect of AEA. Furthermore, the ethanolamine (EA) generated in this reaction is the metabolite responsible for the protective response. The elevation in the levels of reactive oxygen species during low serum-induced apoptosis is not affected by AEA or EA. On the other hand, AEA and EA reduce caspase 3/7 activity, and AEA attenuates the cleavage of PARP-1. Taken together, our results demonstrate a role for AEA and EA in the protection against low serum-induced apoptosis. Topics: Amidohydrolases; Animals; Apoptosis; Arachidonic Acids; Caspase 3; Caspase 7; Cell Line, Tumor; DNA Fragmentation; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamine; Flow Cytometry; Ischemia; Mice; Neuroblastoma; Polyunsaturated Alkamides; Reactive Oxygen Species; Receptors, Cannabinoid; TRPV Cation Channels | 2007 |